UK markets closed

Madrigal Pharmaceuticals, Inc. (0JXI.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
226.68+14.20 (+6.68%)
At close: 05:02PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.44
52-week change 311.19%
S&P500 52-week change 322.38%
52-week high 3313.00
52-week low 3122.87
50-day moving average 3231.01
200-day moving average 3217.37

Share statistics

Avg vol (3-month) 3201
Avg vol (10-day) 3347
Shares outstanding 515.39M
Implied shares outstanding 6N/A
Float 812.31M
% held by insiders 115.37%
% held by institutions 193.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-47.41%
Return on equity (ttm)-123.98%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -379.97M
Net income avi to common (ttm)-373.63M
Diluted EPS (ttm)-14.65
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)634.13M
Total cash per share (mrq)31.87
Total debt (mrq)117.19M
Total debt/equity (mrq)28.91%
Current ratio (mrq)5.38
Book value per share (mrq)20.39

Cash flow statement

Operating cash flow (ttm)-324.23M
Levered free cash flow (ttm)-192.38M